Viewing Study NCT02077803


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-19 @ 11:49 AM
Study NCT ID: NCT02077803
Status: COMPLETED
Last Update Posted: 2014-09-03
First Post: 2014-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Healthy View
None Canagliflozin View
None Metformin View
None Type 2 diabetes mellitus View
None Bioequivalence View
None GLUMETZA® View